Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug - In a surprising turnabout, drugmaker Gilead Sciences asked the Food & Drug admin to rescind orphan status for remdesivir, the company's experimental coronavirus treatment.

submitted by /u/anutensil [link] [comments]

from Health https://ift.tt/3dDzwQ3
via IFTTT